Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Stephenson et al find "alarmingly high rates" of intimate partner violence among male couples

Stafford's findings on gender gap in children's allowances suggest entrenched nature of wage gap

Sastry et al. find parents with childhood trauma more likely to have children with behavioral health problems

More News

Highlights

Social Science One making available data that "may rival the total amount that currently exists in the social sciences"

West et al. examine HS seniors' nonmedical use of prescription stimulants to boost study

Bobbi Low retires

Seefeldt promoted to associate professor of social work, associate professor of public policy

More Highlights

Next Brown Bag

More PSC brown bags, Fall 2018

Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States

Publication Abstract

Weir, David, Kenneth M. Langa, R.S. Wilson, S.E. Leurgans, D.A. Evans, L.E. Hebert, B.L. Plassman, B.J. Small, an, et al. 2011. "Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States." Alzheimer's and Dementia, 7(1): 74-79.

Background: The prevalence of Alzheimer's disease (AD) in the United States was estimated at 2.3 million in 2002 by the Aging, Demographics, and Memory Study (ADAMS), which is almost 50% less than the estimate of 4.5 million in 2000 derived from the Chicago Health and Aging Project. Methods: We considered how differences in diagnostic criteria may have contributed to these differences in AD prevalence. Results: We identified several important differences in diagnostic criteria that may have contributed to the differing estimates of AD prevalence. Two factors were especially noteworthy. First, the Diagnostic and Statistical Manual of Mental Disorders III-R and IV criteria of functional limitation documented by an informant used in ADAMS effectively concentrated the diagnosis of dementia toward a relatively higher level of cognitive impairment. ADAMS separately identified a category of cognitive impairment not dementia and within that group there were a substantial number of cases with "prodromal" AD (a maximum of 1.95 million with upweighting). Second, a substantial proportion of dementia in ADAMS was attributed to either vascular disease (representing a maximum of 0.59 million with upweighting) or undetermined etiology (a maximum of 0.34 million), whereas most dementia, including mixed dementia, was attributed to AD in the Chicago Health and Aging Project. Conclusion: The diagnosis of AD in population studies is a complex process. When a diagnosis of AD excludes persons meeting criteria for vascular dementia, when not all persons with dementia are assigned an etiology, and when a diagnosis of dementia requires an informant report of functional limitations, the prevalence is substantially lower and the diagnosed cases most likely have a relatively higher level of impairment. (C) 2011 The Alzheimer's Association. All rights reserved.

DOI:10.1016/j.jalz.2010.11.006 (Full Text)

PMCID: PMC3145367. (Pub Med Central)

Country of focus: United States of America.

Browse | Search : All Pubs | Next